DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the target of a significant decline in short interest in May. As of May 31st, there was short interest totalling 456,700 shares, a decline of 13.7% from the May 15th total of 529,000 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 4,567.0 days.
DiaSorin Price Performance
DiaSorin stock remained flat at $109.00 during midday trading on Monday. The company’s 50 day moving average price is $103.79 and its 200-day moving average price is $98.16. DiaSorin has a 52-week low of $86.00 and a 52-week high of $115.38.
Analysts Set New Price Targets
Separately, Barclays began coverage on shares of DiaSorin in a report on Thursday, May 9th. They issued an “equal weight” rating for the company.
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Read More
- Five stocks we like better than DiaSorin
- What to Know About Investing in Penny Stocks
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- What Are Dividend Champions? How to Invest in the Champions
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- Options Trading – Understanding Strike Price
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.